Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Board Change/Director Dealing

7 Feb 2008 09:41

Jarvis Securities plc07 February 2008 Jarvis Securities plc ("Jarvis" or "the Company") Board Change/Director's Shareholding/Transaction in Own Shares Jarvis Securities plc, the administration and outsourcing operation whichsupplies retail execution only stock broking facilities as well as outsourcedinvestment services and Model B settlement, is pleased to announce theappointment of Graeme McAusland B.Sc to the Board as a Non-Executive Directorwith effect from 1 March 2008. Graeme (aged 42) has held a number of senior positions and is on the Board ofThe Children's Mutual where he holds the post of Chief Operating Officerresponsible for all financial and governance areas including compliance, riskmanagement and audit functions. He has implemented and managed a number of newoperating and business models to enhance and increase the scale of business,having previously held the position of Financial Director and Appointed Actuary. Prior to this, Graeme held various management roles including Head of CorporateDevelopment with Prudential plc and is a Fellow of the Faculty of Actuaries. Graeme owns no shares or options in the Company at the present time. The following information is disclosed pursuant to Rule 17, Schedule Two (g) ofthe AIM Rules for Companies: Current Appointments Tunbridge Wells Insurance Services Limited Tunbridge Wells Equitable Investments Company Limited Tunbridge Wells Equitable Services Company Graeme is also a member of the Management Board of the Tunbridge Wells EquitableFriendly Society Limited There is no further information to disclose. Commenting on the appointment of Graeme to the Board, Andrew Grant, Chairman andChief Executive said: "We are delighted that Graeme has agreed to join the Board of Jarvis. He willbring his undoubted personal drive and expertise to enhance the Company'sstrategy and operations" John Mackay, who has been a non-Executive Director of the Company since 2004,has in view of his other business commitments agreed to stand down as anon-Executive Director effective from 29 February 2008. John has been veryhelpful to us over the last 3 years and we would like to thank him for hiscontribution to the Company's development and wish him well for the future. On 5 February, prior to John's departure, he exercised Options previouslygranted to him under the 2004 scheme pursuant to which he has acquired 50,000Ordinary Shares at a price of 82.5p per share. Following this purchase, John isbeneficially interested in 50,000 Ordinary Shares representing approximately 0.4per cent. of the Company's current issued share capital. The shares have beensatisfied from Treasury. The Company announces that between 1 February 2008 and 6 February 2008 itacquired 49,000 shares at an average price of 200.562p to be held in Treasury.Following these transactions and the sale of shares to Mr Mackay, the Companynow holds nil Ordinary Shares in Treasury and has 10,800,000 Ordinary Shares inissue. For further information: Jarvis Securities plcAndrew Grant, Chairman & CEO Tel: 0870 224 1111 Daniel Stewart & Company plcLindsay Mair/Tessa Smith Tel: 020 7776 6550 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Nov 20173:45 pmRNSDividend Declaration
7th Nov 20174:20 pmRNSTotal Voting Rights
1st Sep 20177:00 amRNSTransaction in Own Shares
29th Aug 201712:09 pmRNSDirectors' Interests
4th Aug 201711:00 amRNSDividend Declaration
31st Jul 20172:14 pmRNSDirectors' interests
20th Jul 20177:00 amRNSInterim Results - Six Months End 30 June 2017
24th May 20172:50 pmRNSNotification of Major Interest in Shares
11th May 20177:00 amRNSDividend Declaration and Trading Statement
4th May 20177:00 amRNSExercise of options
24th Apr 20173:28 pmRNSEXERCISE OF OPTIONS AND TRANSACTION IN OWN SHARES
21st Apr 20171:07 pmRNSPDMR Dealings
10th Apr 20174:55 pmRNSDirectors' Interests
23rd Mar 20171:45 pmRNSResult of Annual General Meeting
16th Mar 20177:00 amRNSExercise of options
28th Feb 201710:20 amRNSExercise of options
16th Feb 20177:00 amRNSFinal Results
6th Feb 20173:34 pmRNSDividend Declaration
6th Jan 20177:00 amRNSDirector/PDMR Shareholding
28th Nov 201611:30 amRNSExercise of options
8th Nov 20161:19 pmRNSDividend Declaration
7th Sep 20168:43 amRNSDirectors' Interests & Transaction in Own Shares
6th Sep 201612:48 pmRNSDirector/PDMR Shareholding
2nd Aug 201610:50 amRNSTransaction in Own Shares
21st Jul 20167:00 amRNSHalf-year Report
8th Jul 201610:34 amRNSDividend Declaration
7th Jul 20168:13 amRNSHolding(s) in Company
3rd Jun 20163:22 pmRNSHolding(s) in Company
3rd Jun 20167:00 amRNSTransaction in Own Shares
18th May 20167:00 amRNSExecution of Heads of Terms
10th May 201611:34 amRNSDividend Declaration
31st Mar 20164:18 pmRNSDirectors' Interests
24th Mar 201611:45 amRNSResult of AGM
18th Mar 20163:07 pmRNSDirector/PDMR Shareholding
15th Mar 20169:35 amRNSDirector/PDMR Shareholding
14th Mar 201612:02 pmRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSTransaction in Own Shares
3rd Mar 201611:31 amRNSReplacement - Transaction in Own Shares
3rd Mar 20167:00 amRNSTransaction in Own Shares
25th Feb 201611:59 amRNSDirector/PDMR Shareholding
22nd Feb 201610:01 amRNSDirector/PDMR Shareholding
18th Feb 201612:33 pmRNSTransaction in Own Shares
18th Feb 20167:00 amRNSFinal Results
9th Feb 20169:51 amRNSDividend Declaration
9th Dec 20157:00 amRNSTransaction in Own Shares
12th Nov 20157:00 amRNSDividend Declaration
28th Aug 20153:38 pmRNSTransaction in Own Shares
10th Aug 201512:57 pmRNSTransaction in Own Shares
24th Jul 20157:00 amRNSDividend Declaration
23rd Jul 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.